FDA Inspection 1055664 — Abbott
The FDA completed an inspection of Abbott on February 1, 2018 in Plymouth, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 1, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Plymouth, MN (United States)
Additional Details
Postmarket Audit Inspections